Bloodstream infections in patients with chronic lymphocytic leukemia: a longitudinal single-center study

Christian Kjellander1,2, Magnus Björkholm3, Owe Källman4

  • 1Division of Hematology, Department of Medicine, Karolinska University Hospital Solna and Karolinska Institutet, Stockholm, Sweden. Christian.Kjellander@karolinska.se.

Annals of Hematology
|March 16, 2016
PubMed

Insights

Bloodstream infections (BSIs) are a major concern for chronic lymphocytic leukemia (CLL) patients. This study found no significant temporal changes in the distribution of bacterial causes of BSIs in CLL patients between 1988 and 2006.

Area of Science:

  • Hematology
  • Infectious Diseases
  • Epidemiology

Background:

  • Infectious complications are a leading cause of morbidity and mortality in chronic lymphocytic leukemia (CLL).
  • Understanding the trends in bloodstream infections (BSIs) is crucial for managing CLL patients.

Purpose of the Study:

  • To investigate temporal trends in the causative agents of bloodstream infections (BSIs) among patients diagnosed with chronic lymphocytic leukemia (CLL).

Main Methods:

  • Retrospective analysis of blood culture data from CLL patients in Sweden (1988-2006).
  • Data linked with Swedish Cancer Registry, Cause of Death Registry, and Swedish Patient Registry.
  • Patients divided into three time periods based on CLL diagnosis year.

Main Results:

  • Escherichia coli, Streptococcus pneumoniae, Pseudomonas aeruginosa, and Staphylococcus aureus were common BSI pathogens.
  • Coagulase-negative staphylococci were frequent but often contaminants.
  • No significant temporal change in the proportion of Gram-positive to Gram-negative bacteria causing BSIs was observed.

Conclusions:

  • The etiological distribution of BSIs in CLL patients remained stable from 1988 to 2006.
  • This stability suggests consistent management strategies may be effective, but ongoing surveillance is warranted.

Related Concept Videos